| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.01 |